News

Armada appoints Mike Baldzicki as EVP industry relations and advocacy

BY Alaric DeArment

FLORHAM PARK, N.J. — Armada Health Care has appointed Mike Baldzicki as its EVP industry relations and advocacy, the specialty pharmacy group purchasing and channel management company said Friday.

Baldzicki will help the company with business development and find speaking and presentation opportunities at industry events.

Baldzicki is a member of the Academy of Managed Care Pharmacy, the Specialty Pharmacy Association of America, the Pharmaceutical Care Management Association, the Immune Deficiency Foundation Committee and is listed in Strathmore’s Who’s Who for Healthcare Professionals. Baldzicki previously worked at Axelacare Health Solutions as VP strategic contracting and payer relations.


Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Fruth decides to only carry diversion-resistant PSE product Nexafed behind the counter

BY Michael Johnsen

POINT PLEASANT, W.Va. — Fruth Pharmacy on Friday announced their commitment to replace medications containing pseudoephedrine, a nonprescription decongestant that can be used in the illicit manufacture of methamphetamine, with Nexafed, a PSE product formulated with Impede technology that disrupts the extraction and conversion of PSE to meth.

Currently, medications with 30 mg of PSE will be replaced with other mg amounts being replaced as soon as possible, the 27-store chain stated.

“Fruth Pharmacy has long been an advocate in the fight against methamphetamine production,” stated Lynne Fruth, president and chairman for Fruth Pharmacy. “We were excited about the NPLEx system — a cross-state electronic log system — and Nexafed is another tool we are glad to have.”

“The statistics for meth labs in West Virginia alone is staggering,” added Tim Weber, director of pharmacy administration and procurement at Fruth. “If there’s a way to stop people from using medications sold in our pharmacies to produce meth, then we are interested.”

Nexafed is distributed by Acura Pharmaceuticals.


Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

AbbVie releases higher-dose version of pancreatic enzyme-replacement drug

BY Alaric DeArment

NORTH CHICAGO, Ill. — A new, higher-dose formulation of a drug used to treat pancreatic disorders is now available, the drug’s manufacturer said.

AbbVie announced the launch of the new formulation of Creon (pancrelipase) delayed-release capsules. The drug is used to treat exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, removal of the pancreas and other conditions. The new strength is the highest-dose pancreatic enzyme replacement therapy available in the United States, AbbVie said.

"Patients with [exocrine pancreatic insufficiency] require replacement of enzymes to help them break down food into nutrients," University of Pittsburgh gastroenterology, hepatology and nutrition division chief David Whitcomb said. "Obtaining adequate lipase doses, however, often means taking a large number of capsules with each meal. A higher-lipase capsule dose is an option for some patients, and it may help reduce the number of capsules they take when compared to lower-lipase products."


Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES